Showing results (1111-1120 of 1,139) with videos related to
Sort By:
Pageof 114
The Lancet. Oncology|April 4, 2018
3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trialTimothy J Iveson, Rachel S Kerr, Mark P Saunders, et al.Health Technology Assessment (Winchester, England)|December 20, 2019
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCTTimothy Iveson, Kathleen A Boyd, Rachel S Kerr, et al.Pain|April 9, 2016
Pain intensity rating training: results from an exploratory study of the ACTTION PROTECCT systemShannon M Smith, Dagmar Amtmann, Robert L Askew, et al.The Lancet. Gastroenterology & Hepatology|December 15, 2022
Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trialPaula Ghaneh, Daniel Palmer, Silvia Cicconi, et al.The New England Journal of Medicine|October 1, 2019
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E-Mutated Colorectal CancerScott Kopetz, Axel Grothey, Rona Yaeger, et al.British Journal of Cancer|November 14, 2018
SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancerJosé Robles-Zurita, Kathleen A Boyd, Andrew H Briggs, et al.Indian Journal of Pharmacology|April 30, 2024
Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of IndiaPreeta Kaur Chugh, Pooja Gupta, Himika Wasan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2025
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic AdenocarcinomaPascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, et al.The Journal of Pain|October 5, 2022
Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and RecommendationsRobert R Edwards, Kristin L Schreiber, Robert H Dworkin, et al.Pain|May 7, 2016
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendationsRobert R Edwards, Robert H Dworkin, Dennis C Turk, et al.Pageof 114